Pfizer

Undeterred by Pfizer's looming OTC sale, Merck KGaA scouts consumer health bidders
Fierce Pharma
Tue, 10/31/17 - 09:12 pm
Pfizer
Merck KGaA
M&A
consumer health
OTC
[forum discussion] Is Pfizer going to acquire Celgene?
Cafepharma Message Boards
Tue, 10/31/17 - 11:22 am
Pfizer
Celgene
M&A
Pfizer beats 3Q net forecasts on lower charges, higher sales
Yahoo/AP
Tue, 10/31/17 - 10:08 am
Pfizer
earnings
Latecomer Verzenio stands out from Ibrance, Kisqali in launch's early days: Lilly
Fierce Pharma
Mon, 10/30/17 - 10:00 am
Verzenio
Ibrance
Kisqali
drug launches
breast cancer. Eli Lilly
Pfizer
Novartis
What to expect from the rest of pharma's earnings
BioPharma Dive
Mon, 10/30/17 - 09:52 am
earnings
Pfizer
Allergan
Novo Nordisk
Sanofi
AstraZeneca
Earnings Preview: What To Expect From Pfizer On Tuesday
Forbes
Sat, 10/28/17 - 10:54 am
earnings
Pfizer
3 Key Things to Watch in Pfizer's Q3 Results
Motley Fool
Fri, 10/27/17 - 11:06 am
Pfizer
earnings
Sanofi, J&J could join GlaxoSmithKline, Reckitt in $20B bidding war for Pfizer OTC: report
Fierce Pharma
Thu, 10/26/17 - 10:58 am
Sanofi
JNJ
GSK
Reckitt Benckiser
Pfizer
M&A
consumer health
OTC
Reader poll: Pfizer most likely buyer for Spark
Biopharma Dive
Wed, 10/25/17 - 10:39 pm
Pfizer
Spark Therapeutics
M&A
GlaxoSmithKline eyes Pfizer's OTC unit. But will a buy imperil its dividend?
Fierce Pharma
Wed, 10/25/17 - 10:13 pm
GSK
M&A
Pfizer
OTC
consumer health
What’s driving the rapid growth of the top 20 biopharma companies in the world?
Endpoints
Wed, 10/25/17 - 11:24 am
JNJ
Roche
Pfizer
Novartis
Merck
Serono
AbbVie
Sanofi
Amgen
Bayer
GSK
Is a Beat Likely for Pfizer (PFE) This Earnings Season?
Yahoo/Zacks.com
Wed, 10/25/17 - 10:48 am
Pfizer
earnings
Pneumonia vaccine triples protection in animal models
Fierce Biotech
Sat, 10/21/17 - 10:20 am
vaccines
pneumonia
antibiotic resistance
Merck
Pneumovax 23
Pfizer
Prevnar 13
Pfizer, NEA back Cydan II’s plans to launch a fresh slate of biotech startups focused on rare genetic diseases
Endpoints
Wed, 10/18/17 - 08:45 am
Pfizer
NEA
Cydan
biotech
After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorlatinib, heads to the FDA
Endpoints
Mon, 10/16/17 - 12:00 pm
Pfizer
lorlatinib
FDA
non-small cell lung cancer
Reckitt Benckiser is the most likely buyer of Pfizer’s Consumer Healthcare business
GoinPharma
Fri, 10/13/17 - 11:57 am
Reckitt Benckiser
Pfizer
M&A
consumer health
With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica
Fierce Pharma
Fri, 10/13/17 - 09:34 am
Pfizer
FDA
Lyrica
generics
Lyrica CR
shingles
diabetic peripheral neuropathy
Is Pfizer the Best Dividend Stock in Healthcare?
Motley Fool
Wed, 10/11/17 - 10:59 pm
Pfizer
dividends
3 Reasons Why Pfizer Investors Will Win With a Consumer Business Sale or Spinoff
Motley Fool
Wed, 10/11/17 - 09:55 am
Pfizer
consumer health
M&A
Pfizer to explore potential sale, spinoff of consumer healthcare business
Marketwatch
Tue, 10/10/17 - 09:33 am
Pfizer
consumer health
M&A

Pages